![Hans David Ulmert, MD, PhD](https://www.sloankettering.edu/sites/default/files/styles/large/public/node/102601/3x2/ulmert_161107_12_3x2.jpg)
My clinical research is focused on the study of risk factors and biomarkers related to clinically diagnosed prostate cancer and definitive end-points in non-screened cohorts. The findings of these studies extend into my translational research, which center on development of novel in vivo strategies targeting enzymes regulated by the molecular pathways that drive the disease. The overarching goal is to apply these specific tissue targeting vehicles for multimodal molecular imaging strategies, as well as for carriers of therapeutic agents.